USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
CANCER GENETICS, INC.
Address:
201Route 17 North
Rutherford, NJ
Phone:
N/A
URL:
N/A
EIN:
43462475
DUNS:
15091395
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $896,267.00 7
SBIR Phase II $1,709,016.00 3

Award List:

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase I
Award Amount:
$132,371.00
Agency:
HHS
Principal Investigator:
Ramana V. Tantravahi
Abstract:
N/a

FISH ASSAY FOR THE DETECTION OF T (14;18) (Q32;21)

Award Year / Program / Phase:
2001 / SBIR / Phase I
Award Amount:
$0.00
Agency:
HHS
Principal Investigator:
Ramana V. Tantravahi
Abstract:
DESCRIPTION (applicant's abstract): Approximately 60 percent of B-cell lymphomas are characterized by the presence of the t(14;18) (q32;q21) chromosomal translocation. Diagnosis and post-treatment follow-up are currently performed by karyotype, Southern blotting, or… More

FISH ASSAY FOR THE DETECTION OF T (14;18) (Q32;21)

Award Year / Program / Phase:
2001 / SBIR / Phase II
Award Amount:
$417,956.00
Agency:
HHS
Principal Investigator:
Ramana V. Tantravahi
Abstract:
DESCRIPTION (applicant's abstract): Approximately 60 percent of B-cell lymphomas are characterized by the presence of the t(14;18) (q32;q21) chromosomal translocation. Diagnosis and post-treatment follow-up are currently performed by karyotype, Southern blotting, or… More

MOLECULAR PROBES FOR BURKITT'S AND MANTLE CELL LYMPHOMA

Award Year / Program / Phase:
2001 / SBIR / Phase I
Award Amount:
$158,425.00
Agency:
HHS
Principal Investigator:
Nallasivam Palanisamy
Abstract:
APPLICANT?S DESCRIPTION: The goal of this research is to develop two fluorescence in situ hybridization (FISH) assays for the detection of the t(11;14)(q13;q32) and the t(8;14)(q24;q32) chromosomal translocations encountered in Mantle and Burkitt?s B-cell Lymphoma respectively. These tumors are… More

FISH Assay for Acute Myeloid Leukemia

Award Year / Program / Phase:
2001 / SBIR / Phase I
Award Amount:
$226,508.00
Agency:
HHS
Principal Investigator:
Nallasivam Palanisamy
Abstract:
DESCRIPTION (Applicant's abstract): The goal of this research is to develop two fluorescence in situ hybridization (FISH) assays for detecting the t(8;21)(q22;q22) and inv(16)(p13q22) and related t(16;16)(p13;q22) translocations found in two different subsets… More

HIGH THROUGHPUT SYSTEM FOR FISH ANALYSIS

Award Year / Program / Phase:
2002 / SBIR / Phase I
Award Amount:
$186,145.00
Agency:
HHS
Principal Investigator:
Abstract:
Minimum Residual Disease (MRD) is currently identified using pathologic examination, cytogenetics, fluorescence activated cell sorting, and polymerase chain reaction (PCR). Pathologic examination, which assesses cancer cell morphology, is the standard method, but the detection limit is only 10/-1 to… More

Development and Validation of a FISH-Based Renal Cancer Detection Assay

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$93,253.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Increased routine use of state-of-the-art imaging techniques has resulted in a higher incidence of small incidentally discovered renal masses, benign and malignant. A large proportion of patients with such masses, are w ithin an older, more frail population and… More

Development of a FISH-Based HPV-Associated Cancer Detection Test

Award Year / Program / Phase:
2009 / SBIR / Phase I
Award Amount:
$99,565.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): A causative role of high-risk human papillomavirus (HPV) types in human cancer has been established, particularly for those of the anogenital region including cervical and anal cancers. The etiologic course of such canc ers is thought to involve HPV infection,… More

Development and Validation of a FISH-Based Renal Cancer Detection Assay

Award Year / Program / Phase:
2010 / SBIR / Phase II
Award Amount:
$645,168.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Increased routine use of state-of-the-art imaging techniques has resulted in a higher incidence of small incidentally discovered renal masses, benign and malignant. A large proportion of patients with such masses, are w ithin an older, more frail population and… More

Development of a FISH-Based HPV-Associated Cancer Detection Test

Award Year / Program / Phase:
2012 / SBIR / Phase II
Award Amount:
$645,892.00
Agency:
HHS
Principal Investigator:
Jane Houldsworth – 201-528-9171
Abstract:
DESCRIPTION (provided by applicant): A causative role of high-risk human papillomavirus (HPV) types in human cancer has been established, particularly for those of the anogenital region including cervical and anal cancers. The etiologic course of such cancers is thought to involve HPV infection,… More